Long-term follow-up of idiopathic chronic pericardial effusion

Article Abstract:

Many people with idiopathic chronic pericardial effusion can live a normal life with no serious health problems. Pericardial effusion is a build-up of fluid around the heart. When it persists for more than three months and has no apparent cause, it is called idiopathic chronic pericardial effusion. In a study of 28 such patients who were followed for up to 20 years, 13 had no symptoms when the condition was first detected. Twenty-nine percent developed cardiac tamponade, a life-threatening condition. Many were adequately treated by draining the excess fluid or removing the membrane that surrounds the heart.

Prognosis, Pericardial effusion

---

Long-term vasodilator therapy in patients with severe aortic regurgitation

Article Abstract:

An experiment to evaluate whether vasodilator treatment can minimize the left ventricular volume and mass and enhance left ventricular functioning in patients with aortic regurgitation is undertaken. Prolonged vasodilator treatment with nifedipine or enalapril did not minimize or postpone the need for aortic-valve replacement in patients, neither did the aortic regurgitant volume and the size of the left ventricle decrease and the treatment did not enhance the left ventricular performance.

Science & research, Research, Dosage and administration, Long-term care of the sick, Long term care

---

Long-term vasodilator therapy in patients with severe aortic regurgitation

Article Abstract:

An experiment to evaluate whether vasodilator treatment can minimize the left ventricular volume and mass and enhance left ventricular functioning in patients with aortic regurgitation is undertaken. Prolonged vasodilator treatment with nifedipine or enalapril did not minimize or postpone the need for aortic-valve replacement in patients, neither did the aortic regurgitant volume and the size of the left ventricle decrease and the treatment did not enhance the left ventricular performance.

United States, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Vasodilators, Health aspects, Vasodilator agents

Similar abstracts:

• Abstracts: Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
• Abstracts: Screening for psychosocial risk factors in patients with chronic orofacial pain: Recent advances. Are female patients with orofacial pain medically compromised?
• Abstracts: Costimulation blockade with belatacept in renal transplantation. Immunosuppressive drugs for kidney transplantation
• Abstracts: Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. Intensive insulin therapy and pentastarch resuscitation in severe sepsis

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.